Kim, Heesun
Ryu, Choongho
Lee, Mase
Lee, Kyeong-Ryoon
Kim, Juhee http://orcid.org/0000-0003-4778-3041
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia
https://doi.org/10.1007/s12325-024-02890-1
Funding for this research was provided by:
inventageLab
Article History
Received: 25 March 2024
Accepted: 29 April 2024
First Online: 4 June 2024
Declarations
:
: The authors declare that the clinical trial is related to drugs with commercial significance, and no conflicts of interest may influence the objectivity and integrity of the study process.
: This study was conducted according to the Therapeutic Goods Administration (TGA) and Human Research Ethics Committee (HREC) guidelines. The whole study was conducted in accordance with the provisions of the Helsinki Declaration and the standards for clinical trial management (GCP), and the protocol was registered at (NCT04945226; Reg date 2021–06-30). Potential volunteers completed signed informed consent and underwent a screening test prior to the trial.